Recalls & Warnings September 24, 2024 Manufacturer of Mushroom Gummies Warned by FDA for Violations On August 13, 2024, the FDA issued a Warning Letter to Restorative Botanicals, LLC, following an inspection of the companys facility found the companys products, including its My GUT Shrooms Gummies and My IMMUNE Shrooms Capsules, to be adulterated because they were prepared,
Evaluating suppliers involves comparing key attributes relevant to B2B procurement
Both questions failed by the same 67 tally with one abstention
So, glutathione has been well known for over 30 years, but it has been more popular to the general population due to the advent of new technologies
The announcement was widely interpreted as a signal that the FDA under the new administration would take a more permissive stance toward peptide compounding than the 2023 Pharmacy Compounding Advisory Committee position, which had placed BPC-157 firmly in Category 2 (substances the FDA had concerns about for compounding use)